Promoting the Progress of Science: Avoiding Inherent Obviousness

Podcast / September 16, 2020

You’ve thought long and hard about how your company’s clinical stage invention is novel over anything that’s ever been done before. Your analysis is finished, right? Not even close. The novelty barrier to patentability can be high, but the obviousness barrier can be even higher. Stephanie Lodise discusses the concept of “inherent obviousness” and strategies for avoiding it.

Questions & Comments: slodise@bakerlaw.com

Subscribe to BakerHosts

Apple Podcast | Google Podcast | iHeartRadio | Spotify | Stitcher | TuneIn

Download Episode Transcript